Related content

Resistance to Chemotherapy and Molecularly Targeted Therapies: Rationale for Combination Therapy in Malignant Melanoma

By  

Current Molecular Medicine, Vol. 11, Iss. 7, 2011-10 ,pp. : 553-563

Bentham Science Publishers

Access to resources Recommend Favorite

Efficacy and resistance of gemtuzumab ozogamicin for acute myeloid leukemia

By Takeshita Akihiro  

International Journal of Hematology, Vol. 97, Iss. 6, 2013-06 ,pp. : 703-716

Springer Publishing Company

Access to resources Recommend Favorite

MicroRNAs in hematological malignancies: a novel approach to targeted therapy

By Joshi Dolly   Gosh Kanjaksha   Vundinti Babu Rao  

Hematology, Vol. 17, Iss. 3, 2012-05 ,pp. : 170-175

Maney Publishing

Access to resources Recommend Favorite

FLT3 inhibitors for acute myeloid leukemia: a review of their efficacy and mechanisms of resistance

By Grunwald Michael  

International Journal of Hematology, Vol. 97, Iss. 6, 2013-06 ,pp. : 683-694

Springer Publishing Company

Access to resources Recommend Favorite

Early efficacy of stereotactic body radiation therapy combined with adoptive immunotherapy for advanced malignancies

By          

Molecular and Clinical Oncology, Vol. 1, Iss. 5, 2013-01 ,pp. : 925-929

Spandidos Publications

Access to resources Recommend Favorite